EDIT Editas Medicine, Inc. - Common Stock

NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗
$3.03
मूल्य · अग 24, 2026
मौलिकता इस प्रकार है अग 5, 2026

Editas Medicine, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

और पढ़ें

Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

History

Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures. The name was changed to the current "Editas Medicine" two months later. Doudna quit in June 2014 over legal differences concerning intellectual property of Cas9.

In August 2015, the company raised $120 million in Series B funding from Bill Gates and 13 other investors. it went public on 2 February 2016, via a $94 million initial public offering.

Editas entered into a strategic collaboration with Juno Therapeutics in 2015 to create a chimeric antigen receptor and high-affinity T cell receptor therapeutics to the end of developing cancer therapeutics. Juno was later acquired by Celgene, which was in turn acquired by Bristol Myers Squibb.

The company announced in 2015 that it was planning a clinical trial using CRISPR gene editing techniques to treat Leber congenital amaurosis type 10 (LCA10), a rare genetic illness that causes blindness. On 30 November 2018, the FDA gave permission to start the trials, under the investigational name EDIT-101 (also known as AGN-151587). In September 2021, a statement from Editas claimed that preliminary results from clinical trials were promising and support clinical benefits of EDIT-101 treatment.

In March 2020, Editas, in partnership with Allergan, was the first to use CRISPR to try to edit DNA inside a person's body (in vivo). As part of the clinical trial, a patient who was nearly blind as a result of Leber's congenital amaurosis received an intravitreal injection containing a harmless virus carrying CRISPR gene-editing instructions. Five months later, Editas reworked its deal with Allergan's owner AbbVie and regained full rights to their range of eye disease treatment therapies, including EDIT-101 for the treatment of LCA10.

In 2019, the company was building new chemistry facilities in Boulder, Colorado.

Katrine Bosley was CEO until 2019, when she was replaced by board member Cynthia Collins. Collins was replaced in 2021 by James Mullen, who had been board chairman. Gilmore O'Neill, former CMO of Sarepta Therapeutics, became CEO on June 1, 2022, with Mullen staying on as executive chairman of the board.

On December 12, 2024, Editas ended the development of reni-cel and laid off 65% of its employees.

Research

Editas works with two different CRISPR nucleases, Cas9 and Cas12a.

EDIT-101 is a CRISPR based gene therapy for treatment of Leber congenital amaurosis, currently in clinical trials.

EDIT-301 is an experimental potential treatment utilizing the firm's CAS 12a editing technology for sickle cell disease and beta-thalassemia. In 2019 the firm reported early success in research on the drug;. In December 2020, it filed an IND application for treatment of sickle cell disease. In January 2021, it said it had received clearance from the FDA for phase 1 safety studies.

== References ==

स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗

Wikidata ↗

EDIT स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा

मूल्य
$3.03
मार्केट कैप
$297M
P/E (TTM)
-1.7
EPS (TTM)
$-1.80
राजस्व (TTM)
$41M
लाभांश प्रतिफल
ROE
-688.8%
D/E ऋण/इक्विटी
2.1
52W रेंज
$2 – $5

EDIT स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें

10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान

राजस्व और शुद्ध आय $41M
10-point trend, +569.4%
2016-12-31 2025-12-31
EPS $-1.80
7-point trend, +32.8%
2019-12-31 2025-12-31
फ्री कैश फ्लो $-166M
10-point trend, -210.5%
2016-12-31 2025-12-31
मार्जिन -395.0%

मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?

मेट्रिक
5Y रुझान
EDIT
सहकर्मी माध्यिका
P/E (TTM)
5-point trend, +87.8%
-1.7
16.6
P/S (TTM)
5-point trend, -93.0%
7.3
10.1
P/B
5-point trend, +124.0%
10.9
4.8
EV / EBITDA
2-point trend, -264.5%
-1.3
Price / FCF (मूल्य / FCF)
5-point trend, +88.6%
-1.8

लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC

मेट्रिक
5Y रुझान
EDIT
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
5-point trend, +47.8%
-394.9%
Net Profit Margin (शुद्ध लाभ मार्जिन)
5-point trend, +47.6%
-395.0%
-175.8%
ROA
5-point trend, -96.8%
-60.6%
-34.7%
ROE
5-point trend, -1940.2%
-688.8%
-54.4%

वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती

मेट्रिक
5Y रुझान
EDIT
सहकर्मी माध्यिका
Debt / Equity (ऋण / इक्विटी)
2-point trend, +402.1%
2.1
0.0
Current Ratio (वर्तमान अनुपात)
5-point trend, -67.2%
3.5
6.9
Quick Ratio (त्वरित अनुपात)
5-point trend, -67.2%
3.5

विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR

मेट्रिक
5Y रुझान
EDIT
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
5-point trend, +58.6%
25.4%
Revenue CAGR 3Y (राजस्व CAGR 3Y)
5-point trend, +58.6%
27.2%
Revenue CAGR 5Y (राजस्व CAGR 5Y)
5-point trend, +58.6%
-14.9%

प्रति शेयर मेट्रिक्स EPS, प्रति शेयर बुक वैल्यू, प्रति शेयर नकदी प्रवाह, प्रति शेयर लाभांश

मेट्रिक
5Y रुझान
EDIT
सहकर्मी माध्यिका
EPS (Diluted) (EPS (तनुभूत))
5-point trend, +36.8%
$-1.80

पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर

मेट्रिक
5Y रुझान
EDIT
सहकर्मी माध्यिका

EDIT विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड

खरीदें 18 विश्लेषक
  • मजबूत खरीद 4 22.2%
  • खरीदें 8 44.4%
  • होल्ड 4 22.2%
  • बेचें 2 11.1%
  • मजबूत बिक्री 0 0.0%

12-महीने का मूल्य लक्ष्य

9 विश्लेषक · 2026-08-23
मध्यिका लक्ष्य $5.00 +65.0%
माध्य लक्ष्य $6.00 +98.0%

Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि

औसत आश्चर्य
-0.03%
Period EPS Actual EPS अनुमान आश्चर्य
30 जून 2026 $-0.15 $-0.28 0.13%
31 मार्च 2026 $-0.26 $-0.27 0.01%
31 दिसमबर 2025 $-0.06 $-0.26 0.20%
30 सितमबर 2025 $-0.28 $-0.30 0.02%
30 जून 2025 $-0.63 $-0.38 -0.25%
31 मार्च 2025 $-0.92 $-0.60 -0.32%

सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी

टिकर मार्केट कैप P/E राजस्व YoY शुद्ध मार्जिन ROE सकल मार्जिन
EDIT $201M -1.1 25.4% -395.0% -688.8%
KYTX $568M -2.6 -77.4%
EVMN $540M -1.5 85.7% -529.8% -401.2%
MPLT $773M -0.9 -151.1%
CCCC $185M -1.5 1.0% -292.1% -48.8%
RZLT $388M -4.6 -56.9%
OCGN $422M -5.6 8.8% -1537.4% 1488.8%
QTTB $43M 1.4 55.5% 200.3%
PBYI $300M 9.8 -0.91% 13.6% 26.5%
BNTC $307M -11.1 -43.8%
PROK 1075.0% -7725.2% 6.9%

पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह

आय विवरण 13
EDIT के लिए वार्षिक आय विवरण डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue 10-point trend, +569.4% $41M $32M $78M $20M $26M $91M $21M $32M $14M $6M
R&D Expense 10-point trend, +57.9% $90M $199M $178M $175M $143M $158M $97M $91M $83M $57M
SG&A Expense 10-point trend, +7.9% $50M $72M $70M $71M $76M $68M $65M $55M $51M $46M
Operating Expenses 10-point trend, +94.2% $201M $283M $247M $246M $219M $226M $161M $146M $134M $103M
Operating Income 10-point trend, -64.6% $-160M $-251M $-169M $-226M $-193M $-135M $-141M $-114M $-120M $-97M
Other Non-op 10-point trend, -3740.4% $-2M $-3.0K $-2M $0 $37.0K $16M $-137.0K $328.0K $587.0K $-57.0K
Income Tax Flat — no change across 5 periods $0 $0 $0 $0 $0 · · · · ·
Net Income 10-point trend, -64.7% $-160M $-237M $-153M $-220M $-193M $-116M $-134M $-110M $-120M $-97M
EPS (Basic) 7-point trend, +32.8% $-1.80 $-2.88 $-2.02 $-3.21 $-2.85 $-1.98 $-2.68 · · ·
EPS (Diluted) 7-point trend, +32.8% $-1.80 $-2.88 $-2.02 $-3.21 $-2.85 $-1.98 $-2.68 · · ·
Shares (Basic) 7-point trend, +77.6% 88,745,908 82,338,220 75,965,633 68,664,822 67,619,388 58,609,389 49,983,329 · · ·
Shares (Diluted) 7-point trend, +77.6% 88,745,908 82,338,220 75,965,633 68,664,822 67,619,388 58,609,389 49,983,329 · · ·
EBITDA 10-point trend, -64.6% $-160M $-251M $-169M $-226M $-193M $-135M $-141M $-114M $-120M $-97M
बैलेंस शीट 24
EDIT के लिए वार्षिक बैलेंस शीट डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, -20.9% $147M $132M $124M $142M $204M $140M $238M $135M $147M $185M
Short-term Investments 9-point trend, -100.0% $0 $138M $199M $203M $296M $262M $219M $234M $183M ·
Receivables 10-point trend, +17145.5% $15M $16M $10M $5M $267.0K $6M $418.0K $30.0K $679.0K $88.0K
Prepaid Expense 10-point trend, +17.0% $2M $3M $8M $7M $7M $11M $6M $6M $2M $2M
Current Assets 10-point trend, -12.4% $164M $289M $341M $357M $507M $419M $464M $375M $332M $187M
PP&E (Net) 10-point trend, -91.2% $4M $14M $12M $16M $17M $14M $11M $40M $39M $40M
PP&E (Gross) 10-point trend, -23.9% $32M $46M $38M $37M $33M $25M $18M $47M $44M $42M
Accum. Depreciation 10-point trend, +1722.2% $28M $32M $26M $22M $16M $11M $7M $7M $4M $2M
Other Non-current Assets 10-point trend, +83.6% $3M $5M $9M $5M $7M $5M $5M $5M $2M $2M
Total Assets 10-point trend, -18.6% $187M $342M $499M $514M $677M $573M $509M $420M $373M $229M
Accounts Payable 10-point trend, -43.9% $3M $5M $8M $10M $5M $6M $6M $5M $4M $5M
Accrued Liabilities 10-point trend, +87.0% $33M $46M $35M $31M $20M $24M $22M $13M $11M $17M
Current Liabilities 10-point trend, +39.8% $46M $77M $63M $60M $47M $58M $60M $36M $37M $33M
Capital Leases 10-point trend, -65.6% $12M $20M $24M $33M $16M $19M $23M $32M $33M $35M
Other Non-current Liabilities 9-point trend, +610.9% $3M $3M $2M $0 · $28M $1.0K $293.0K $317.0K $396.0K
Total Liabilities 10-point trend, +68.4% $159M $207M $150M $154M $124M $179M $246M $184M $165M $95M
Long-term Debt 3-point trend, +58605000.00 $59M $57M $0 · · · · · · ·
Total Debt 2-point trend, +2.0% $59M $57M · · · · · · · ·
Common Stock 10-point trend, +150.0% $10.0K $8.0K $8.0K $7.0K $7.0K $6.0K $5.0K $5.0K $4.0K $4.0K
Retained Earnings 10-point trend, -777.8% $-1.63B $-1.47B $-1.23B $-1.08B $-858M $-665M $-549M $-416M $-306M $-186M
AOCI 9-point trend, +100.0% $0 $268.0K $198.0K $-4M $-493.0K $-46.0K $107.0K $-29.0K $-76.0K ·
Stockholders' Equity 10-point trend, -79.7% $27M $134M $349M $361M $554M $394M $262M $236M $208M $135M
Liabilities + Equity 10-point trend, -18.6% $187M $342M $499M $514M $677M $573M $509M $420M $373M $229M
Shares Outstanding 10-point trend, +173.2% 97,866,996 82,734,696 81,767,263 68,847,382 68,435,257 62,563,457 54,355,798 48,758,951 44,507,960 35,818,131
नकदी प्रवाह 10
EDIT के लिए वार्षिक नकदी प्रवाह डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Stock-based Comp 10-point trend, -40.8% $10M $21M $20M $29M $43M $23M $27M $27M $23M $17M
Restructuring 3-point trend, +12232000.00 · $12M $0 $0 · · · · · ·
Operating Cash Flow 10-point trend, -228.9% $-165M $-210M $-132M $-177M $-164M $-180M $-41M $-46M $-9M $-50M
CapEx 10-point trend, -82.6% $607.0K $9M $5M $4M $8M $7M $6M $5M $2M $3M
Investing Cash Flow 10-point trend, +4092.7% $139M $162M $-4M $114M $-54M $-141M $12M $-53M $-184M $-3M
Stock Issued 10-point trend, -56.0% $43M $0 $117M $0 $249M $204M $116M $77M $154M $97M
Net Stock Activity 9-point trend, -56.0% $43M $0 $117M · $249M $204M $116M $77M $154M $97M
Financing Cash Flow 10-point trend, -58.3% $40M $56M $118M $1M $282M $224M $132M $87M $155M $97M
Net Change in Cash 10-point trend, -68.0% $14M $8M $-18M $-62M $64M $-96M $103M $-12M $-39M $43M
Free Cash Flow 10-point trend, -210.5% $-166M $-219M $-137M $-181M $-172M $-187M $-47M $-50M $-11M $-53M
लाभप्रदता 5
EDIT के लिए वार्षिक लाभप्रदता डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Operating Margin 8-point trend, -10.9% -394.9% -777.2% -216.6% -1146.3% -756.1% -148.6% -686.4% -356.1% · ·
Net Margin 8-point trend, -14.7% -395.0% -733.7% -196.1% -1118.3% -753.6% -127.8% -651.4% -344.3% · ·
EBITDA Margin 8-point trend, -10.9% -394.9% -777.2% -216.6% -1146.3% -756.1% -148.6% -686.4% -356.1% · ·
ROA 10-point trend, -18.0% -60.6% -56.4% -30.2% -37.0% -30.8% -21.4% -28.8% -27.7% -40.0% -51.3%
ROE 10-point trend, -82.5% -688.8% -153.0% -43.2% -56.9% -33.8% -27.8% -56.6% -47.7% -70.2% -377.5%
तरलता और शोधन क्षमता 4
EDIT के लिए वार्षिक तरलता और शोधन क्षमता डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -37.4% 3.5 3.7 5.4 5.9 10.8 7.2 7.7 10.4 9.1 5.7
Quick Ratio 10-point trend, -37.6% 3.5 3.7 5.3 5.8 10.7 7.0 7.6 10.3 9.0 5.6
Debt / Equity 2-point trend, +402.1% 2.1 0.4 · · · · · · · ·
LT Debt / Equity 2-point trend, +403.0% 2.0 0.4 · · · · · · · ·
दक्षता 2
EDIT के लिए वार्षिक दक्षता डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +90.6% 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.1 · ·
Receivables Turnover 8-point trend, -97.1% 2.6 2.4 10.2 7.3 8.1 28.1 91.7 90.1 · ·
प्रति शेयर 5
EDIT के लिए वार्षिक प्रति शेयर डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -92.6% $0.28 $1.62 $4.27 $5.24 $8.09 $6.29 $4.83 $4.84 $4.68 $3.76
Revenue / Share 5-point trend, +20.9% $0.46 $0.39 $1.03 $0.29 $0.38 · · · · ·
Cash Flow / Share 5-point trend, +23.1% $-1.86 $-2.55 $-1.74 $-2.58 $-2.42 · · · · ·
Cash / Share 10-point trend, -71.0% $1.50 $1.59 $1.51 $2.06 $2.97 $2.23 $4.38 $2.76 $3.29 $5.17
EPS (TTM) 7-point trend, +32.8% $-1.80 $-2.88 $-2.02 $-3.21 $-2.85 $-1.98 $-2.68 · · ·
विकास दरें 3
EDIT के लिए वार्षिक विकास दरें डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, +135.3% 25.4% -58.6% 296.3% -22.8% -71.9% · · · · ·
Revenue CAGR 3Y 3-point trend, +657.5% 27.2% 8.2% -4.9% · · · · · · ·
Revenue CAGR 5Y -14.9% · · · · · · · · ·
मूल्यांकन (TTM) 14
EDIT के लिए वार्षिक मूल्यांकन (TTM) डेटा
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +569.4% $41M $32M $78M $20M $26M $91M $21M $32M $14M $6M
Net Income TTM 10-point trend, -64.7% $-160M $-237M $-153M $-220M $-193M $-116M $-134M $-110M $-120M $-97M
Market Cap 10-point trend, -65.5% $201M $105M $828M $611M $1.82B $4.39B $1.61B $1.11B $1.37B $581M
Enterprise Value 2-point trend, +204.8% $113M $-107M · · · · · · · ·
P/E 7-point trend, +89.7% -1.1 -0.4 -5.0 -2.8 -9.3 -35.4 -11.0 · · ·
P/S 10-point trend, -94.8% 5.0 3.3 10.6 31.0 71.1 48.3 78.4 34.7 99.6 96.0
P/B 10-point trend, +70.2% 7.4 0.8 2.4 1.7 3.3 11.1 6.1 4.7 6.6 4.3
P / Tangible Book 6-point trend, -34.0% 7.4 0.8 2.4 1.7 3.3 11.1 · · · ·
P / Cash Flow 10-point trend, +89.6% -1.2 -0.5 -6.3 -3.4 -11.1 -24.4 -39.6 -24.3 -145.2 -11.6
P / FCF 10-point trend, +88.9% -1.2 -0.5 -6.1 -3.4 -10.6 -23.5 -34.4 -22.0 -119.2 -10.9
EV / EBITDA 2-point trend, -264.5% -0.7 0.4 · · · · · · · ·
EV / FCF 2-point trend, -238.5% -0.7 0.5 · · · · · · · ·
EV / Revenue 2-point trend, +183.6% 2.8 -3.3 · · · · · · · ·
Earnings Yield 7-point trend, -870.2% -87.8% -226.8% -19.9% -36.2% -10.7% -2.8% -9.0% · · ·

वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष

आय विवरण
2025-12-312024-12-312023-12-312022-12-312021-12-31
राजस्व $41M$32M$78M$20M$26M
परिचालन मार्जिन % -394.9%-777.2%-216.6%-1146.3%-756.1%
शुद्ध आय $-160M$-237M$-153M$-220M$-193M
तनुकरणित EPS $-1.80$-2.88$-2.02$-3.21$-2.85
बैलेंस शीट
2025-12-312024-12-312023-12-312022-12-312021-12-31
ऋण / इक्विटी 2.10.4
वर्तमान अनुपात 3.53.75.45.910.8
त्वरित अनुपात 3.53.75.35.810.7
नकदी प्रवाह
2025-12-312024-12-312023-12-312022-12-312021-12-31
फ्री कैश फ्लो $-166M$-219M$-137M$-181M$-172M

मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ

📊

उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।

आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।

संस्थागत मालिक (13F) 239 फाइलर्स · $327.2M कुल · तिथि अनुसार 30 जून 2026

संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।

संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
नई स्थितियाँ बाहर निकली पोजीशन बढ़ाया घटा हुआ शुद्ध शेयर परिवर्तन
37 (-6 पिछली तिमाही की तुलना में) 22 (-4 पिछली तिमाही की तुलना में) 79 (+23 पिछली तिमाही की तुलना में) 42 (-9 पिछली तिमाही की तुलना में) +67.4M

Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।

संस्था मूल्य शेयर % ट्रैक किए गए 13F का प्रकार
TCG Crossover Management, LLC $36000000 11111111 11.00% शेयर
RA CAPITAL MANAGEMENT, L.P. $28800360 8889000 8.80% शेयर
Commodore Capital LP $28800360 8889000 8.80% शेयर
ADAR1 Capital Management, LLC $28800360 8889000 8.80% शेयर
VANGUARD CAPITAL MANAGEMENT LLC $19897929 6141336 6.08% शेयर
Paradigm Biocapital Advisors LP $18100665 5586625 5.53% शेयर
Opaleye Management Inc. $12512653 3861930 3.82% शेयर
VANGUARD PORTFOLIO MANAGEMENT LLC $11658618 3598339 3.56% शेयर
Woodline Partners LP $11519810 3555497 3.52% शेयर
Vivo Capital, LLC $11519010 3555250 3.52% शेयर
GordonMD Global Investments LP $10131480 3127000 3.10% शेयर
RENAISSANCE TECHNOLOGIES LLC $7999298 2468919 2.45% शेयर
Logos Global Management LP $7199280 2222000 2.20% शेयर
GEODE CAPITAL MANAGEMENT, LLC $7134030 2201290 2.18% शेयर
STATE STREET CORP $7101442 2191803 2.17% शेयर
GOLDMAN SACHS GROUP INC $6763843 2087606 2.07% शेयर
TWO SIGMA INVESTMENTS, LP $4318842 1332976 1.32% शेयर
Seven Fleet Capital Management LP $4310820 1330500 1.32% शेयर
RAYMOND JAMES FINANCIAL INC $4201156 1296653 1.28% शेयर
MARSHALL WACE, LLP $4044048 1248163 1.24% शेयर
D. E. Shaw & Co., Inc. $3715178 1146660 1.14% शेयर
KENNEDY CAPITAL MANAGEMENT LLC $3344111 1032133 1.02% शेयर
MACKENZIE FINANCIAL CORP $2844856 878042 0.87% शेयर
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $2812424 868032 0.86% शेयर
Nantahala Capital Management, LLC $2762748 852700 0.84% शेयर
TWO SIGMA ADVISERS, LP $2509405 1224100 0.77% शेयर
VANGUARD FIDUCIARY TRUST CO $2407158 742950 0.74% शेयर
BlackRock, Inc. $1813920 559852 0.55% शेयर
MILLENNIUM MANAGEMENT LLC $1616750 498997 0.49% शेयर
Susquehanna Portfolio Strategies, LLC $1545801 477099 0.47% शेयर
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1521180 469500 0.46% कॉल ऑप्शन
Eversept Partners, LP $1486541 458809 0.45% शेयर
Casdin Capital, LLC $1441800 445000 0.44% शेयर
PEAK6 LLC $1346029 415441 0.41% शेयर
DIADEMA PARTNERS LP $1296000 400000 0.40% कॉल ऑप्शन
BIT Capital GmbH $1056240 326000 0.32% शेयर
Cubist Systematic Strategies, LLC $994094 286482 0.30% शेयर
LOS ANGELES CAPITAL MANAGEMENT LLC $878642 271186 0.27% शेयर
BANK OF AMERICA CORP /DE/ $751119 231827 0.23% शेयर
LPL Financial LLC $748813 231115 0.23% शेयर
Erste Asset Management GmbH $736000 230000 0.22% शेयर
IEQ CAPITAL, LLC $705623 217785 0.22% शेयर
Walleye Capital LLC $595703 183859 0.18% शेयर
SUSQUEHANNA INTERNATIONAL GROUP, LLP $558900 172500 0.17% पुट ऑप्शन
CITADEL ADVISORS LLC $557604 172100 0.17% पुट ऑप्शन
DAFNA Capital Management LLC $552323 170470 0.17% शेयर
Mariner, LLC $548500 169291 0.17% शेयर
Green Alpha Advisors, LLC $505589 156046 0.15% शेयर
PEAK6 LLC $497340 153500 0.15% कॉल ऑप्शन
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $490555 151406 0.15% शेयर
BARCLAYS PLC $476030 146923 0.15% शेयर
ALLIANCEBERNSTEIN L.P. $464187 187930 0.14% शेयर
JACOBS LEVY EQUITY MANAGEMENT, INC $445030 137355 0.14% शेयर
BRIDGEWAY CAPITAL MANAGEMENT, LLC $408240 126000 0.12% शेयर
Point72 Asset Management, L.P. $405758 125234 0.12% शेयर
RHUMBLINE ADVISERS $380421 117417 0.12% शेयर
JPMORGAN CHASE & CO $376528 117665 0.12% शेयर
JANE STREET GROUP, LLC $374473 115578 0.11% शेयर
FMR LLC $348384 107526 0.11% शेयर
HSBC HOLDINGS PLC $314481 97062 0.10% शेयर
Bank of New York Mellon Corp $309378 95487 0.09% शेयर
WELLINGTON MANAGEMENT GROUP LLP $303462 93661 0.09% शेयर
SUSQUEHANNA INTERNATIONAL GROUP, LLP $300818 92845 0.09% शेयर
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $300226 92094 0.09% शेयर
AMERICAN CENTURY COMPANIES INC $300011 92596 0.09% शेयर
CWM, LLC $259352 105001 0.08% शेयर
MORGAN STANLEY $237324 73248 0.07% शेयर
CITADEL ADVISORS LLC $229392 70800 0.07% कॉल ऑप्शन
OSAIC HOLDINGS, INC. $222928 68806 0.07% शेयर
SEI INVESTMENTS CO $221188 68268 0.07% शेयर
Nuveen, LLC $221188 68268 0.07% शेयर
Joel Isaacson & Co., LLC $220787 68144 0.07% शेयर
JANE STREET GROUP, LLC $218376 67400 0.07% पुट ऑप्शन
SIMPLEX TRADING, LLC $207275 63974 0.06% शेयर
MetLife Investment Management, LLC $182140 56216 0.06% शेयर
CITIGROUP INC $182052 56189 0.06% शेयर
CITADEL ADVISORS LLC $173923 53680 0.05% शेयर
MML INVESTORS SERVICES, LLC $168765 52088 0.05% शेयर
GROUP ONE TRADING LLC $163131 50349 0.05% शेयर
Creative Planning $147653 45572 0.05% शेयर
China Universal Asset Management Co., Ltd. $143934 44424 0.04% शेयर
WINTON GROUP Ltd $141588 43700 0.04% शेयर
Vanguard Global Advisers, LLC $138876 42863 0.04% शेयर
CANADA PENSION PLAN INVESTMENT BOARD $137376 42400 0.04% शेयर
Graham Capital Management, L.P. $134369 41472 0.04% शेयर
Quinn Opportunity Partners LLC $129600 40000 0.04% शेयर
Invesco Ltd. $128178 39561 0.04% शेयर
Vanguard Personalized Indexing Management, LLC $124108 38305 0.04% शेयर
MERCER GLOBAL ADVISORS INC /ADV $121967 37644 0.04% शेयर
Balyasny Asset Management L.P. $121947 37638 0.04% शेयर
AXQ CAPITAL, LP $118104 36452 0.04% शेयर
Nuveen Asset Management, LLC $113934 89712 0.03% शेयर
SCS Capital Management LLC $113400 35000 0.03% शेयर
Police & Firemen's Retirement System of New Jersey $109749 33873 0.03% शेयर
Thrive Wealth Management, LLC $108540 33500 0.03% शेयर
TWO SIGMA SECURITIES, LLC $107367 33138 0.03% शेयर
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC $102359 31207 0.03% शेयर
CAPTRUST FINANCIAL ADVISORS $98159 30296 0.03% शेयर
HORIZON KINETICS ASSET MANAGEMENT LLC $89683 27680 0.03% शेयर
MANUFACTURERS LIFE INSURANCE COMPANY, THE $88339 27265 0.03% शेयर

कंपनी के अंदरूनी सूत्र 34 इनसाइडर्स · 15 अधिकारी · 16 निदेशक

अंदरूनी भूमिका अंतिम गतिविधि शेयरों का स्वामित्व खरीद 12m बिक्री 12m नेट 12m
Gilmore Neil O'Neill CEO 3 जून 2026 S 248313 0 1 $-41543
MULLEN JAMES C CEO 14 अप्रैल 2022 A 75898 0 0 $0
Cynthia Collins CEO 9 फ़रवरी 2021 S 43760 0 0 $0
Katrine Bosley President and CEO 8 जनवरी 2019 S 1204966 0 0 $0
Erick Lucera EVP, CHIEF FINANCIAL OFFICER 17 मई 2023 A 77900 0 0 $0
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER 11 मई 2023 S 106610 0 0 $0
Andrew A. F. Hack Chief Financial Officer 4 फ़रवरी 2019 M 0 0 0 $0
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER 28 जुलाई 2026 S 62369 0 2 $-15133
Bruce Eaton EVP, CBO AND CTO 11 अगस्त 2023 S 75831 0 0 $0
Baisong Mei SVP, CHIEF MEDICAL OFFICER 19 जुलाई 2023 S 72055 0 0 $0
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER 13 फ़रवरी 2023 S 65559 0 0 $0
Lisa Anne Michaels EVP/Chief Medical Officer 22 दिसमबर 2021 A 22675 0 0 $0
Judith R Abrams Chief Medical Officer 28 अक्टूबर 2019 A 25000 0 0 $0
Vickesh Myer Chief Technology Officer 18 मार्च 2019 M 0 0 0 $0
Gerald Frank Cox Chief Medical Officer 7 फ़रवरी 2018 A 4000 0 0 $0
Elliott M. Levy निदेशक 17 जून 2026 A 0 0 $0
David Scadden निदेशक 17 जून 2026 A 0 0 $0
Bernadette Connaughton निदेशक 17 जून 2026 A 0 0 $0
Jessica Hopfield निदेशक 17 जून 2026 A 22700 0 0 $0
Andrew Hirsch निदेशक 17 जून 2026 A 0 0 $0
Meeta Chatterjee निदेशक 1 जून 2023 A 0 0 $0
Emma Reeve निदेशक 1 जून 2023 A 0 0 $0
Akshay Vaishnaw निदेशक 1 जून 2023 A 0 0 $0
Boris Nikolic निदेशक 15 जून 2018 A 35000 0 0 $0
Douglas G. Cole निदेशक 17 अगस्त 2017 J 3171 0 0 $0
Kevin Bitterman निदेशक 15 जून 2017 A 2797144 0 0 $0
Alexis Borisy निदेशक 15 जून 2017 A 0 0 0 $0
John Mendlein निदेशक 15 जून 2017 A 0 0 $0
Kevin P Starr 10% मालिक 6 सितमबर 2016 S 0 0 0 $0
bng0, LLC 10% मालिक 8 फ़रवरी 2016 C 2649572 0 0 $0
Patrick Thomas Ellinor II 6 अगस्त 2026 A 0 0 $0
Amy Parison 3 अगस्त 2026 S 14292 0 2 $-3002
Charles Albright 15 दिसमबर 2020 M 24907 0 0 $0
Alexandra Glucksmann 15 मार्च 2017 M 117788 0 0 $0

SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S

कार्यकर्ता और 5%+ मालिक 1 होल्डिंग

जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।

फाइलर दाखिल किया दांव स्थिति उद्देश्य फाइलिंग
Polaris Venture Partners VI, L.P. (“PVP VI”), Polaris Venture Founders’ Fund VI, L.P. (“PVPFF VI”), Polaris Venture Management Co. VI, L.L.C. (“PVM VI”), Jonathan A. Flint (“Flint”), Terrance G. McGuire (“McGuire”), Brian Chee (“Chee”), David Barrett (“Barrett”), Amir Nashat (“Nashat”), Bryce Youngren (“Youngren”) ×4 फाइलिंग 18 सितमबर 2017 प्रारंभिक फाइलिंग SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ईटीएफ स्वामित्व 30 ETFs द्वारा धारित

वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।

फंड भार इकाइयाँ तिथि अनुसार स्रोत
QQQS · Invesco Exchange-Traded Fund Trust … 0.42% 32319 SH 21 अगस्त 2026 दैनिक
NXTE · INVESTMENT MANAGERS SERIES TRUST II 0.35% 61197 NS 30 जून 2026 N-PORT
GNOM · Global X Funds 0.34% 54725 NS 31 मई 2026 N-PORT
IWC · iShares Trust 0.07% 346478 SH 21 अगस्त 2026 दैनिक
IBB · iShares Trust 0.03% 1053931 SH 21 अगस्त 2026 दैनिक
IBBQ · Invesco Exchange-Traded Fund Trust … 0.03% 8933 SH 21 अगस्त 2026 दैनिक
VTWG · VANGUARD SCOTTSDALE FUNDS 0.02% 96927 SH 19 अगस्त 2026 दैनिक
BIB · ProShares Trust 0.02% 3611 NS 31 मई 2026 N-PORT
IWO · iShares Trust 0.02% 844017 SH 21 अगस्त 2026 दैनिक
TMFX · RBB Fund, Inc. 0.02% 1527 NS 31 मई 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 118731 SH 21 अगस्त 2026 दैनिक
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 575834 SH 19 अगस्त 2026 दैनिक
VHT · VANGUARD WORLD FUND 0.01% 461967 SH 19 अगस्त 2026 दैनिक
IWM · iShares Trust 0.01% 2595929 SH 21 अगस्त 2026 दैनिक
RSSL · Global X Funds 0.01% 42610 NS 30 अप्रैल 2026 N-PORT
RB · ProShares Trust 0.01% 29 NS 31 मई 2026 N-PORT
ITWO · ProShares Trust 0.01% 4633 NS 31 मई 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.01% 476309 NS 31 मई 2026 N-PORT
UWM · ProShares Trust 0.01% 3622 NS 31 मई 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0.00% 32379 NS 31 मई 2026 N-PORT
URTY · ProShares Trust 0.00% 3660 NS 31 मई 2026 N-PORT
IWN · iShares Trust 0.00% 120487 SH 21 अगस्त 2026 दैनिक
HDG · ProShares Trust 0.00% 92 NS 31 मई 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.00% 2922 NS 31 मई 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0.00% 96350 NS 31 मई 2026 N-PORT
IWV · iShares Trust 0.00% 19062 SH 21 अगस्त 2026 दैनिक
VXF · VANGUARD INDEX FUNDS 0.00% 1100306 SH 19 अगस्त 2026 दैनिक
VTI · VANGUARD INDEX FUNDS 0.00% 4890144 SH 19 अगस्त 2026 दैनिक
VTWV · VANGUARD SCOTTSDALE FUNDS 0.00% 9046 SH 19 अगस्त 2026 दैनिक
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 7608 SH 19 अगस्त 2026 दैनिक